BIA submission to the Lord Hill review of UK listing rules

The BIA has written to Lord Hill responding to his call for evidence on the UK's listing rules. 

BIA response to the National Security and Investment Bill

UK quoted biotech performance and investor base in 2020

This report is an exclusive analysis of the performance of the UK-quoted biotech sector and the breadth of its investor base by Radnor Capital Partners on behalf of the BIA.